Suchergebnisse - "Harman, Katie"

PubPharm (16)

1

Comparison of the risk of hospitalisation among BA.1 and BA.2 COVID-19 cases treated with Sotrovimab in the community in England

enthalten in: bioRxiv.org | 2024

von Harman, K. | Nash, S. | Webster, H. | +13

2

Vaccine effectiveness against hospitalisation estimated using a test-negative case-control study design, and comparative odds of hospital admission and severe outcomes with COVID-19 sub-lineages BQ.1, CH.1.1. and XBB.1.5 in England

enthalten in: The Lancet regional health. Europe | 2023

von Kirsebom, F. | Harman, K. | Lunt, R. | +10

3

COVID-19 therapeutics : stewardship in England and considerations for antimicrobial resistance

enthalten in: The Journal of antimicrobial chemotherapy | 2023

von Bou-Antoun, S. | Rokadiya, S. | Ashiru-Oredope, D. | +18

4

Representativeness of whole-genome sequencing approaches in England : the importance for understanding inequalities associated with SARS-CoV-2 infection

enthalten in: Epidemiology and infection | 2023

von Twohig, K. | Harman, K. | Zaidi, A. | +13

5

Vaccine effectiveness against hospitalisation and comparative odds of hospital admission and severe outcomes with BQ.1, CH.1.1. and XBB.1.5 in England

enthalten in: bioRxiv.org | 2023

von Kirsebom, F. | Harman, K. | Lunt, R. | +10

6

Comparison of the risk of hospitalisation among BA.1 and BA.2 COVID-19 cases treated with sotrovimab in the community in England

enthalten in: Influenza and other respiratory viruses | 2023

von Harman, K. | Nash, S. | Webster, H. | +13

7

Hospitalization and Mortality Risk for COVID-19 Cases With SARS-CoV-2 AY.4.2 (VUI-21OCT-01) Compared to Non-AY.4.2 Delta Variant Sublineages

enthalten in: The Journal of infectious diseases | 2022

von Nyberg, T. | Harman, K. | Zaidi, A. | +14

8

Risk of hospitalisation and death in children with SARS-CoV-2 delta (B.1.612.2) infection

enthalten in: The Lancet. Child & adolescent health | 2022

von Thelwall, S. | Aiano, F. | Harman, K. | +2

9

Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England : a cohort study

enthalten in: Lancet (London, England) | 2022

von Nyberg, T. | Ferguson, N. | Nash, S. | +50

CommentIn: Lancet. 2022 Apr 2;399(10332):1280-1281. - PMID 35305298

10

Interpretation of COVID-19 case fatality risk measures in England

enthalten in: Journal of epidemiology and community health | 2021

von Harman, K. | Allen, H. | Kall, M. | +1